DVAX vs. CBOE

Last updated Jun 4, 2026

DVAX (Dynavax Technologies Corporation) and CBOE (Cboe Global Markets, Inc.) are both stocks. DVAX operates in Drug Manufacturers - Specialty & Generic (Healthcare), while CBOE operates in Financial Data & Stock Exchanges (Financial Services). At a 0.12 correlation, their price movements are largely independent.

Performance

DVAX vs. CBOE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dynavax Technologies Corporation (DVAX) and Cboe Global Markets, Inc. (CBOE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

DVAX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CBOE

• 1D: 3.45%
• 1M: -15.70%
• YTD: 14.10%
• 6M: 12.80%
• 1Y: 26.75%
• 3Y*: 29.74%
• 5Y*: 22.18%
• 10Y*: 17.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DVAX vs. CBOE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DVAX Dynavax Technologies Corporation	0.78%	20.44%	-8.66%	31.39%	-24.38%	216.18%	-22.20%	-37.49%	-51.07%	373.42%
CBOE Cboe Global Markets, Inc.	14.10%	29.96%	10.74%	44.37%	-2.16%	42.23%	-21.17%	24.16%	-20.60%	70.49%

Correlation

The correlation between DVAX and CBOE is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.04
Correlation (3Y) Calculated over the trailing 3-year period	-0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (10Y) Calculated over the trailing 10-year period	0.09
Correlation (All Time) Calculated using the full available price history since Jun 16, 2010	0.12

The correlation between DVAX and CBOE shifts across timeframes, from -0.04 (1 year) to 0.12 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap DVAX : $2.12B CBOE : $29.94B
EPS DVAX : -$0.32 CBOE : $11.77
PS Ratio DVAX : 6.44 CBOE : 6.25
PB Ratio DVAX : 3.96 CBOE : 5.57
Total Revenue (TTM) DVAX : $330.51M CBOE : $4.79B
Gross Profit (TTM) DVAX : $274.90M CBOE : $2.50B
EBITDA (TTM) DVAX : -$25.65M CBOE : $1.87B

Return for Risk

DVAX vs. CBOE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBOE

CBOE Risk / Return Rank: 68
CBOE Sharpe Ratio Rank: 71
CBOE Sortino Ratio Rank: 63
CBOE Omega Ratio Rank: 65
CBOE Calmar Ratio Rank: 62
CBOE Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVAX vs. CBOE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dynavax Technologies Corporation (DVAX) and Cboe Global Markets, Inc. (CBOE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	DVAX	CBOE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.00	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.96	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.71	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.66	—

Drawdowns

Drawdown Indicators

	DVAX	CBOE	Difference
Max Drawdown Largest peak-to-trough decline	—	-43.23%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-24.69%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-24.69%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-24.69%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-43.23%	—
Current Drawdown Current decline from peak	—	-22.09%	—
Average Drawdown Average peak-to-trough decline	—	-11.39%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	4.38%	—

Volatility

Volatility by Period

	DVAX	CBOE	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	15.84%	—
Volatility (6M) Calculated over the trailing 6-month period	—	23.69%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	27.03%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	23.16%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	25.31%	—

Dividends

DVAX vs. CBOE - Dividend Comparison

DVAX has not paid dividends to shareholders, while CBOE's dividend yield for the trailing twelve months is around 1.01%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CBOE Cboe Global Markets, Inc.	1.01%	1.08%	1.21%	1.18%	1.56%	1.38%	1.68%	1.12%	1.19%	0.83%	1.30%	1.36%
DVAX Dynavax Technologies Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

DVAX vs. CBOE - Profitability Comparison

The chart below illustrates the profitability comparison between Dynavax Technologies Corporation and Cboe Global Markets, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DVAX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dynavax Technologies Corporation reported a gross profit of 80.47M and revenue of 94.88M. Therefore, the gross margin over that period was 84.8%.

CBOE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cboe Global Markets, Inc. reported a gross profit of 669.90M and revenue of 1.27B. Therefore, the gross margin over that period was 52.6%.

DVAX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dynavax Technologies Corporation reported an operating income of 21.27M and revenue of 94.88M, resulting in an operating margin of 22.4%.

CBOE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cboe Global Markets, Inc. reported an operating income of 505.60M and revenue of 1.27B, resulting in an operating margin of 39.7%.

DVAX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dynavax Technologies Corporation reported a net income of 26.93M and revenue of 94.88M, resulting in a net margin of 28.4%.

CBOE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cboe Global Markets, Inc. reported a net income of 385.70M and revenue of 1.27B, resulting in a net margin of 30.3%.

Frequently Asked Questions

Can I hold both DVAX and CBOE in my portfolio?

DVAX and CBOE have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.